{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T20:47:16Z","timestamp":1773780436858,"version":"3.50.1"},"reference-count":37,"publisher":"Bentham Science Publishers Ltd.","issue":"8","funder":[{"DOI":"10.13039\/501100003399","name":"Shanghai Municipal Science and Technology Major Project","doi-asserted-by":"publisher","award":["2018SHZDZX01"],"award-info":[{"award-number":["2018SHZDZX01"]}],"id":[{"id":"10.13039\/501100003399","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Nature Science Foundation of China","doi-asserted-by":"publisher","award":["81671280"],"award-info":[{"award-number":["81671280"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Nature Science Foundation of China","doi-asserted-by":"publisher","award":["81801289"],"award-info":[{"award-number":["81801289"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"Nature Science Foundation of China","doi-asserted-by":"publisher","award":["31771188"],"award-info":[{"award-number":["31771188"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CNSNDDT"],"published-print":{"date-parts":[[2019,12,30]]},"abstract":"<jats:sec><jats:title>Background &amp; Objective:<\/jats:title><jats:p>Tenidap, a selective human inwardly rectifying potassium (Kir) 2.3 channel opener, has been reported to have antiepileptic effect in the pilocarpine temporal lobe epilepsy rat model in our previous study. However, the effect of tenidap on neurons and its relationship with the epileptiform bursting charges in neuron is still required to be explored.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>In this study, cyclothiazide (CTZ) induced cultured hippocampal neuron epileptic model was used to study the antiepileptic effect of tenidap and the relationship between Kir2.3 channel and the neuronal epileptiform burst.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>Patch clamp recording showed that both acute (2h) and chronic (48h) CTZ pre-treatment all significantly induced robust epileptiform burst activities in cultured hippocampal neurons, and tenidap acutely application inhibited this highly synchronized abnormal activities. The effect of tenidap is likely due to increased activity of Kir2.3 channels, since tenidap significantly enhanced kir current recorded from those neurons. In addition, neurons overexpressing Kir2.3 channels, by transfection with Kir2.3 plasmid, showed a significant large increase of the Kir current, prevented CTZ treatment to induce epileptiform burst discharge.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Our current study demonstrated that over activation of Kir2.3 channel in hippocampal neurons could positively interference with epileptiform burst activities, and tenidap, as a selective Kir2.3 channel opener, could be a potential candidate for seizure therapy.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1871527318666190807122623","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T12:25:53Z","timestamp":1565180753000},"page":"621-630","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Activation of Kir2.3 Channels by Tenidap Suppresses Epileptiform Burst Discharges in Cultured Hippocampal Neurons"],"prefix":"10.2174","volume":"18","author":[{"given":"Xunyi","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Neurology, Huashan Hospital, State Key Laboratory for Medical Neurobiology MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huashan Hospital, State Key Laboratory for Medical Neurobiology MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanbing","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huashan Hospital, State Key Laboratory for Medical Neurobiology MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guoxiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huashan Hospital, State Key Laboratory for Medical Neurobiology MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huashan Hospital, State Key Laboratory for Medical Neurobiology MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Zhongshan Hospital, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Zang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huashan Hospital, State Key Laboratory for Medical Neurobiology MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, Huashan Hospital, State Key Laboratory for Medical Neurobiology MOE Frontiers Center for Brain Science, and Institutes of Brain Science, Fudan University, Shanghai 200032, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.yebeh.2004.01.005","volume":"5","author":"Ali A.","year":"2004","unstructured":"Ali A.; Ahmad F.J.; Pillai K.K.; Vohora D.; Evidence of the antiepileptic potential of amiloride with neuropharmacological benefits in rodent models of epilepsy and behavior. Epilepsy Behav 2004,5,322-328","journal-title":"Epilepsy Behav"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2174\/1871527317666180828121820","volume":"17","author":"Deng X.","year":"2018","unstructured":"Deng X.; Xie Y.; Chen Y.; Effect of neuroinflammation on ABC transporters. Possible contribution to refractory epilepsy. CNS Neurol Disord Drug Targets 2018,17,728-735","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"12436","DOI":"10.1002\/anie.201403846","volume":"53","author":"Ying X.","year":"2014","unstructured":"Ying X.; Wang Y.; Liang J.; Angiopep-conjugated electro-responsive hydrogel nanoparticles: Therapeutic potential for epilepsy. Angew Chem Int Ed Engl 2014,53,12436-12440","journal-title":"Angew Chem Int Ed Engl"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/187152731701180426141109","volume":"17","author":"Shuzhang Z.","year":"2018","unstructured":"Shuzhang Z.; Yudan Z.; Zhiping Z.; Jie T.; Yong-Hua J.; Understanding genotypes and phenotypes of the mutations in voltage- gated sodium channel \u03b1 subunits in epilepsy. CNS Neurol Disord Drug Targets 2018,17,1-7","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=5","first-page":"463","volume":"16","author":"Ohno Y.","year":"2017","unstructured":"Ohno Y.; Tokudome K.; Therapeutic role of Synaptic Vesicle glycoprotein 2A (SV2A) in modulating epileptogenesis. CNS Neurol Disord Drug Targets 2017,16,463-471","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=6","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.2174\/1871527316666171101132047","volume":"16","author":"Witkin J.M.","year":"2017","unstructured":"Witkin J.M.; Schober D.A.; Gleason S.D.; Targeted Blockade of TARP-\u03b38-associated AMPA receptors: Anticonvulsant activity with the selective antagonist LY3130481 (CERC-611). CNS Neurol Disord Drug Targets 2017,16,1099-1110","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"694","DOI":"10.2174\/1871527315666160720121723","volume":"16","author":"Shiha A.A.","year":"2017","unstructured":"Shiha A.A.; de la Rosa R.F.; Delgado M.; Pozo M.A.; Garc\u00eda-Garc\u00eda L.; Subacute fluoxetine reduces signs of hippocampal damage induced by a single convulsant dose of 4-aminopyridine in rats. CNS Neurol Disord Drug Targets 2017,16,694-704","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1113\/jphysiol.2012.240606","volume":"591","author":"Lerche H.","year":"2013","unstructured":"Lerche H.; Shah M.; Beck H.; Noebels J.; Johnston D.; Vincent A.; Ion channels in genetic and acquired forms of epilepsy. J Physiol 2013,591,753-764","journal-title":"J Physiol"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"272","DOI":"10.2174\/1871527317666180213142403","volume":"17","author":"Zhu Y.","year":"2018","unstructured":"Zhu Y.; Zhang S.; Feng Y.; Xiao Q.; Cheng J.; Tao J.; The Yin and Yang of BK channels in epilepsy. CNS Neurol Disord Drug Targets 2018,17,272-279","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2174\/1871527317666180404104055","volume":"17","author":"Zang K.","year":"2018","unstructured":"Zang K.; Zhang Y.; Hu J.; Wang Y.; The large conductance calcium- and voltage-activated potassium channel (BK) and epilepsy. CNS Neurol Disord Drug Targets 2018,17,248-254","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=11","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molbrainres.2005.05.006","volume":"139","author":"Pruss H.","year":"2005","unstructured":"Pruss H.; Derst C.; Lommel R.; Veh R.W.; Differential distribution of individual subunits of strongly inwardly rectifying potassium channels (Kir2 family) in rat brain. Brain Res Mol Brain Res 2005,139,63-79","journal-title":"Brain Res Mol Brain Res"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.neuint.2013.01.011","volume":"63","author":"Bedner P.","year":"2013","unstructured":"Bedner P.; Steinhauser C.; Altered Kir and gap junction channels in temporal lobe epilepsy. Neurochem Int 2013,63,682-687","journal-title":"Neurochem Int"},{"key":"ref=13","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1152\/physrev.00021.2009","volume":"90","author":"Hibino H.","year":"2010","unstructured":"Hibino H.; Inanobe A.; Furutani K.; Murakami S.; Findlay I.; Kurachi Y.; Inwardly rectifying potassium channels, their structure, function, and physiological roles. Physiol Rev 2010,90,291-366","journal-title":"Physiol Rev"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1748-1716.2010.02108.x","volume":"199","author":"de Boer T.P.","year":"2010","unstructured":"de Boer T.P.; Houtman M.J.; Compier M.; van der Heyden M.A.; The mammalian K(IR)2.x inward rectifier ion channel family, expression pattern and pathophysiology. Acta Physiol (Oxf) 2010,199,243-256","journal-title":"Acta Physiol (Oxf)"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.neulet.2016.02.007","volume":"617","author":"Murata Y.","year":"2016","unstructured":"Murata Y.; Yasaka T.; Takano M.; Ishihara K.; Neuronal and glial expression of inward rectifier potassium channel subunits Kir2.x in rat dorsal root ganglion and spinal cord. Neurosci Lett 2016,617,59-65","journal-title":"Neurosci Lett"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1179\/1743132813Y.0000000157","volume":"35","author":"Xu L.","year":"2013","unstructured":"Xu L.; Hao Y.; Wu X.; Yu P.; Zhu G.; Hong Z.; Tenidap, an agonist of the inwardly rectifying K+ channel Kir2.3, delays the onset of cortical epileptiform activity in a model of chronic temporal lobe epilepsy. Neurol Res 2013,35,561-567","journal-title":"Neurol Res"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(95)91326-2","volume":"346","author":"Madhok R Tenidap.","year":"1995","unstructured":"Madhok R Tenidap.; Lancet 1995,346(8973),481-485","journal-title":"Lancet"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0014-2999(01)01590-4","volume":"435","author":"Liu Y.","year":"2002","unstructured":"Liu Y.; Liu D.; Printzenhoff D.; Coghlan M.J.; Harris R.; Krafte D.S.; Tenidap, a novel anti-inflammatory agent, is an opener of the inwardly rectifying K channel hKir2.3. Eur J Pharmacol 2002,435,153-160","journal-title":"Eur J Pharmacol"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2012.08.054","volume":"1486","author":"Chen B.","year":"2012","unstructured":"Chen B.; Jiang M.; Zhou M.; Both NMDA and non-NMDA receptors mediate glutamate stimulation induced cofilin rod formation in cultured hippocampal neurons. Brain Res 2012,1486,1-13","journal-title":"Brain Res"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41598-017-00196-7","volume":"7","author":"Chen L.","year":"2017","unstructured":"Chen L.; Wan L.; Wu Z.; KCC2 downregulation facilitates epileptic seizures. Sci Rep 2017,7,156","journal-title":"Sci Rep"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1756-6606-6-21","volume":"6","author":"Sun Y.","year":"2013","unstructured":"Sun Y.; Wu Z.; Kong S.; Regulation of epileptiform activity by two distinct subtypes of extrasynaptic GABAA receptors. Mol Brain 2013,6,21","journal-title":"Mol Brain"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1113\/jphysiol.2005.103812","volume":"571","author":"Qi J.","year":"2006","unstructured":"Qi J.; Wang Y.; Jiang M.; Warren P.; Chen G.; Cyclothiazide induces robust epileptiform activity in rat hippocampal neurons both in vitro and in vivo. J Physiol 2006,571,605-618","journal-title":"J Physiol"},{"key":"ref=23","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a022426","volume":"5","author":"Stafstrom C.E.","year":"2015","unstructured":"Stafstrom C.E.; Carmant L.; Seizures and epilepsy: An overview for neuroscientists. Cold Spring Harb Perspect Med 2015,5","journal-title":"Cold Spring Harb Perspect Med"},{"key":"ref=24","first-page":"1010","volume":"16","author":"Naseer M.I.","year":"2017","unstructured":"Naseer M.I.; Rasool M.; Chaudhary A.G.; Chromosomal micro-aberration in a Saudi family with juvenile myoclonic epilepsy. CNS Neurol Disord Drug Targets 2017,16,1010-1017","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=25","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2174\/1871527317666180724150839","volume":"17","author":"Jiang X.W.","year":"2018","unstructured":"Jiang X.W.; Lu H.Y.; Xu Z.; In Silicoanalyses for key genes and molecular genetic mechanism in epilepsy and Alzheimer\u2019s disease. CNS Neurol Disord Drug Targets 2018,17,608-617","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=26","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0006-3495(78)85489-7","volume":"22","author":"Hille B.","year":"1978","unstructured":"Hille B.; Ionic channels in excitable membranes. Current problems and biophysical approaches. Biophys J 1978,22,283-294","journal-title":"Biophys J"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"6240","DOI":"10.1073\/pnas.91.13.6240","volume":"91","author":"Perier F.","year":"1994","unstructured":"Perier F.; Radeke C.M.; Vandenberg C.A.; Primary structure and. characterization of a small-conductance inwardly rectifying potassium channel from human hippocampus. Proc Natl Acad Sci USA 1994,91,6240-6244","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.3760\/cma.j.issn.0366-6999.20122710","volume":"126","author":"Tang X.H.","year":"2013","unstructured":"Tang X.H.; Wu X.Y.; Xu L.; Tenidap is neuroprotective in a pilocarpine rat model of temporal lobe epilepsy. Chin Med J (Engl) 2013,126,1900-1905","journal-title":"Chin Med J (Engl)"},{"key":"ref=29","first-page":"266","volume":"18","author":"Zhang S.","year":"2018","unstructured":"Zhang S.; Zhu Y.; Zhang Z.; Tao J.; Ji Y.; Understanding genotypes and phenotypes of voltage-gated sodium channel mutations in epilepsy. CNS Neurol Disord Drug Targets 2018,18(4),266-272","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=30","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2174\/1871527315666161104163031","volume":"16","author":"Leo A.","year":"2017","unstructured":"Leo A.; Citraro R.; Marra R.; The sphingosine 1-phosphate signaling pathway in epilepsy. A possible role for the immunomodulator drug fingolimod in epilepsy treatment. CNS Neurol Disord Drug Targets 2017,16,311-325","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"ref=31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s004240000380","volume":"441","author":"Ruppersberg J.P.","year":"2000","unstructured":"Ruppersberg J.P.; Intracellular regulation of inward rectifier K+ channels. Pflugers Arch 2000,441,1-11","journal-title":"Pflugers Arch"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1085\/jgp.106.1.25","volume":"106","author":"Wang W.H.","year":"1995","unstructured":"Wang W.H.; Regulation of the hyperpolarization-activated K channel in the lateral membrane of the cortical collecting duct. J Gen Physiol 1995,106,25-43","journal-title":"J Gen Physiol"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/archneur.1976.00500020004002","volume":"33","author":"Fisher R.S.","year":"1976","unstructured":"Fisher R.S.; Pedley T.A.; Moody W.J.; Prince D.A.; The role of extracellular potassium in hippocampal epilepsy. Arch Neurol 1976,33,76-83","journal-title":"Arch Neurol"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0013-4694(76)90118-8","volume":"41","author":"Lothman E.W.","year":"1976","unstructured":"Lothman E.W.; Somjen G.G.; Functions of primary afferents and responses of extracellular K during spinal epileptiform seizures. Electroencephalogr Clin Neurophysiol 1976,41,253-267","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1152\/jn.1988.59.1.259","volume":"59","author":"Traynelis S.F.","year":"1988","unstructured":"Traynelis S.F.; Dingledine R.; Potassium-induced spontaneous electrographic seizures in the rat hippocampal slice. J Neurophysiol 1988,59,259-276","journal-title":"J Neurophysiol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejphar.2009.12.013","volume":"629","author":"Best L.","year":"2010","unstructured":"Best L.; Brown P.D.; Sener A.; Malaisse W.J.; Opposing effects of tenidap on the volume-regulated anion channel and K(ATP) channel activity in rat pancreatic beta-cells. Eur J Pharmacol 2010,629,159-163","journal-title":"Eur J Pharmacol"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0143-4160(93)90013-V","volume":"14","author":"Cleveland P.L.","year":"1993","unstructured":"Cleveland P.L.; Millard P.J.; Showell H.J.; Fewtrell C.M.; Tenidap, a novel inhibitor of calcium influx in a mast cell line. Cell Calcium 1993,14,1-16","journal-title":"Cell Calcium"}],"container-title":["CNS &amp; Neurological Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/174148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T19:38:39Z","timestamp":1721590719000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/174148\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,30]]},"references-count":37,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,12,30]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1871527318666190807122623","relation":{},"ISSN":["1871-5273"],"issn-type":[{"value":"1871-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,30]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-03-13","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-21","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}